CTNM
Contineum TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CTNM vs peer average
47/100
CTNM vs. peer average (C vs. C)
Grade spread
A 3 · B 3 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AVXL is the first available peer comparator.
Anavex provides a market-cap and neuro-biotech risk comparator, but it is only a loose operating peer because pipeline biology and catalyst mix differ materially.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CTNM
Contineum Therapeutics
AVXL
Anavex Life Sciences
Grade
C
F
Momentum
48
4
Value
41
41
Sentiment
58
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs AVXL
CTNM / AVXL
Grade Position
In line
CTNM vs. peer average (C vs. C)
47/100
Momentum
48
CTNMValue
41
CTNMSentiment
58
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CTNM
AVXL is the first peer returned for this comparison set.